Alici E - Search Results

1

Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study.

Jungebluth P, Alici E, Baiguera S, Blomberg P, Bozóky B, Crowley C, Einarsson O, Gudbjartsson T, Le Guyader S, Henriksson G, Hermanson O, Juto JE, Leidner B, Lilja T, Liska J, Luedde T, Lundin V, Moll G, Roderburg C, Strömblad S, Sutlu T, Watz E, Seifalian A, Macchiarini P. Jungebluth P, et al. Among authors: alici e. Lancet. 2011 Dec 10;378(9808):1997-2004. doi: 10.1016/S0140-6736(11)61715-7. Epub 2011 Nov 24. Lancet. 2011. PMID: 22119609 Retracted.

2

SHP-1 localization to the activating immune synapse promotes NK cell tolerance in MHC class I deficiency.

Schmied L, Luu TT, Søndergaard JN, Hald SH, Meinke S, Mohammad DK, Singh SB, Mayer C, Perinetti Casoni G, Chrobok M, Schlums H, Rota G, Truong HM, Westerberg LS, Guarda G, Alici E, Wagner AK, Kadri N, Bryceson YT, Saeed MB, Höglund P. Schmied L, et al. Among authors: alici e. Sci Signal. 2023 Apr 11;16(780):eabq0752. doi: 10.1126/scisignal.abq0752. Epub 2023 Apr 11. Sci Signal. 2023. PMID: 37040441

3

Long-term follow-up of gene-marked CD34+ cells after autologous stem cell transplantation for multiple myeloma.

Alici E, Björkstrand B, Treschow A, Aints A, Smith CI, Gahrton G, Dilber MS. Alici E, et al. Cancer Gene Ther. 2007 Mar;14(3):227-32. doi: 10.1038/sj.cgt.7701006. Epub 2006 Nov 3. Cancer Gene Ther. 2007. PMID: 17082794

4

Anti-myeloma activity of endogenous and adoptively transferred activated natural killer cells in experimental multiple myeloma model.

Alici E, Konstantinidis KV, Sutlu T, Aints A, Gahrton G, Ljunggren HG, Dilber MS. Alici E, et al. Exp Hematol. 2007 Dec;35(12):1839-46. doi: 10.1016/j.exphem.2007.08.006. Exp Hematol. 2007. PMID: 18036444 Free article.

5

Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components.

Alici E, Sutlu T, Björkstrand B, Gilljam M, Stellan B, Nahi H, Quezada HC, Gahrton G, Ljunggren HG, Dilber MS. Alici E, et al. Blood. 2008 Mar 15;111(6):3155-62. doi: 10.1182/blood-2007-09-110312. Epub 2008 Jan 11. Blood. 2008. PMID: 18192509 Free article.

6

Retroviral gene transfer into primary human natural killer cells.

Alici E, Sutlu T, Sirac Dilber M. Alici E, et al. Methods Mol Biol. 2009;506:127-37. doi: 10.1007/978-1-59745-409-4_10. Methods Mol Biol. 2009. PMID: 19110624

7

Impact of chromosome 13 deletion and plasma cell load on long-term survival of patients with multiple myeloma undergoing autologous transplantation.

Paul E, Sutlu T, Deneberg S, Alici E, Björkstrand B, Jansson M, Lerner R, Wallblom A, Gahrton G, Nahi H. Paul E, et al. Among authors: alici e. Oncol Rep. 2009 Jul;22(1):137-42. doi: 10.3892/or_00000416. Oncol Rep. 2009. PMID: 19513515

8

Natural killer cell-based immunotherapy in cancer: current insights and future prospects.

Sutlu T, Alici E. Sutlu T, et al. Among authors: alici e. J Intern Med. 2009 Aug;266(2):154-81. doi: 10.1111/j.1365-2796.2009.02121.x. J Intern Med. 2009. PMID: 19614820 Free article. Review.

9

Constitutional inv(3) in myelodysplastic syndromes.

Gahrton C, Nahi H, Jansson M, Wallblom A, Alici E, Sutlu T, Samuelsson J, Gahrton G. Gahrton C, et al. Among authors: alici e. Leuk Res. 2010 Dec;34(12):1627-9. doi: 10.1016/j.leukres.2010.05.014. Epub 2010 Jun 9. Leuk Res. 2010. PMID: 20542563

10

Suicide gene therapy for graft-versus-host disease.

Georgoudaki AM, Sutlu T, Alici E. Georgoudaki AM, et al. Among authors: alici e. Immunotherapy. 2010 Jul;2(4):521-37. doi: 10.2217/imt.10.19. Immunotherapy. 2010. PMID: 20636006 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

111 results

Search Page